Nurse Practitioner, Adult Health · Brooklyn, NY
NPI
1457565269
Since 2007
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2148 Ocean Ave Fl 5
Brooklyn, NY, 11229
Phone (212) 398-1288
Groups this clinician bills Medicare through
Medicare paid, 2024
$639K
12,415 services
Medicare patients, 2024
4,862
Average age 80
Drug cost, 2024
$2.6M
4,315 prescriptions
Company payments, 2025
$1,363
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Igor Romanov was code 99308 (snf e&m), 3,939 times for 2,953 patients. In total Igor Romanov billed 12,415 services in 33 codes, and Medicare paid $639K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 3,939 | 2,953 | $50.40 | $199K |
| 17003 Destruction Skin Lesion | Office | 2,783 | 321 | $5.11 | $14K |
| 99305 SNF E&M | Office | 2,226 | 2,185 | $93.51 | $208K |
| 99213 Office E&M - Established | Office | 1,020 | 491 | $66.31 | $68K |
| 17000 Destruction Skin Lesion | Office | 661 | 420 | $45.21 | $30K |
| 17110 Destruction Skin Lesion | Office | 381 | 265 | $83.44 | $32K |
| 99203 Office E&M - New | Office | 211 | 211 | $79.85 | $17K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 209 | 52 | $0.72 | $150 |
| 17004 Destruction Skin Lesion | Office | 136 | 85 | $132.41 | $18K |
| 11102 Skin Biopsy | Office | 130 | 121 | $65.20 | $8,476 |
| 10060 Skin | Office | 100 | 85 | $95.82 | $9,582 |
| 99349 Home E&M - New and Established | Office | 100 | 64 | $89.69 | $8,969 |
| 11900 Skin | Office | 90 | 46 | $32.60 | $2,934 |
| 99304 SNF E&M | Office | 71 | 71 | $51.38 | $3,648 |
| 99212 Office E&M - Established | Office | 65 | 53 | $42.71 | $2,776 |
By year: 2022 $519K for 11,453 services; 2023 $551K for 10,143 services; 2024 $639K for 12,415 services.
Medicare prescription drug claims, 2024
In 2024, the drug Igor Romanov prescribed most often to Medicare patients was Halobetasol Propionate, with 529 prescriptions and refills. In total Igor Romanov wrote 4,315 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Halobetasol Propionate Generic | 529 | 537 | 230 | $31K |
| Triamcinolone Acetonide Generic | 410 | 452 | 192 | $13K |
| Ketoconazole Generic | 386 | 395 | 139 | $9,285 |
| Fluocinonide Generic | 307 | 323 | 115 | $16K |
| Mupirocin Generic | 231 | 231 | 133 | $1,431 |
| Ammonium Lactate Generic | 178 | 191 | 72 | $3,490 |
| Opzelura Ruxolitinib Phosphate | 156 | 158 | 48 | $309K |
| Metronidazole Generic | 149 | 150 | 51 | $8,269 |
| Clotrimazole Generic | 146 | 146 | 61 | $3,746 |
| Clindamycin Phosphate Generic | 128 | 132 | 48 | $4,806 |
| Mometasone Furoate Generic | 110 | 112 | 62 | $2,154 |
| Nystatin Generic | 79 | 81 | 33 | $1,140 |
| Imiquimod Generic | 77 | 109 | 43 | $2,029 |
| Silver Sulfadiazine Generic | 75 | 75 | 46 | $722 |
| Econazole Nitrate Generic | 71 | 73 | 32 | $3,003 |
Brand drugs: 637 claims; generic drugs: 3,678 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Igor Romanov $1,363 ($1,363 in general payments such as food, travel and fees) from 15 companies. The largest payer was Janssen Biotech, Inc. with $231.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 5 | $231 |
| Incyte Corporation INCY | 7 | $226 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $217 |
| Genzyme Corporation SNY | 3 | $169 |
| Abbvie Inc. ABBV | 4 | $114 |
| Organon LLC OGN | 4 | $90.77 |
| LEO Pharma Inc. | 2 | $52.39 |
| Amgen Inc. AMGN | 2 | $43.26 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $41.64 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $34.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.